Cirius’ Mixed Phase IIb Results In NASH Don’t Quell Its Enthusiasm For Phase III

 
• By Joseph Haas
  
Glycogen in liver and muscle. Insulin sensitive and Insulin resistant. - Vector
Cirius believes an insulin-sensitizer approach will succeed in NASH
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D